
    
      The study was conducted as a multicenter, randomized, parallel, placebo-controlled,
      double-blind comparative clinical study. Patients were randomly assigned in a double-blind
      manner to receive 45 or 90 mg/day of oral vitamin K2 or an identical-appearing placebo. Study
      drug was administered orally three times daily after meals until recurrence.
    
  